Immutep discontinues lung cancer trial after futility analysis
Go back to Immutep discontinues lung cancer trial after futility analysis| Immtech Pharmaceuticals, Inc. (NASDAQ: IMMP) | Delayed: 0.42 -0.01 (2.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.43 | 52 Week High | $0.01 | |||
| Open | $0.43 | 52 Week Low | $0.00 | |||
| Day High | $0.44 | P/E | N/A | |||
| Day Low | $0.41 | EPS | $0.00 | |||
| Volume | 763,277 | |||||
